ConductScience.org, home

Trial · NCT02956057

Polyethylene Glycol Versus Low Volume Solutions Prior to Colonoscopy

NCT02956057, Phase 4, Completed, Tomas Bata Hospital, Czech Republic; results first posted 2020-10-28

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Polyethylene Glycol Versus Low Volume Solutions Prior to Colonoscopy. Trials, record NCT02956057. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02956057

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Polyethylene Glycol Versus Low Volume Solutions Prior to Colonoscopy
NCT number
NCT02956057
Status
Completed
Phases
Phase 4
Enrollment
1,044 participants, actual
Lead sponsor
Tomas Bata Hospital, Czech Republic
Conditions
Colonoscopy
Interventions
Polyethylene Glycols, Natrium picosulfate / Magnesium citrate, Polyethylene glycol / Ascorbic acid
First posted
2016-11-04
Last updated
2020-10-28
Results first posted
2020-10-28

Source ClinicalTrials.gov

Registered outcomes2

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryQuality of Bowel Preparation Using the Aronchick Scale ( Score 1+2)One dayBowel preparation score 1+2 expressed on Aronchick scale (1 the best, 5 the worst)
SecondaryTolerance of Bowel Preparation Assessed by 5 Point VAS ( Score 1+2)One dayTolerance of Bowel Preparation Assessed by VAS score 1+2 ( 1-excellent, 5-very poor)

Outcomes2

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYQuality of Bowel Preparation Using the Aronchick Scale ( Score 1+2)One dayParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYTolerance of Bowel Preparation Assessed by 5 Point VAS ( Score 1+2)One dayParticipantsCOUNT_OF_PARTICIPANTS

Results by group12

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Quality of Bowel Preparation Using the Aronchick Scale ( Score 1+2)PEG1D110Participants
Quality of Bowel Preparation Using the Aronchick Scale ( Score 1+2)PEG2D145Participants
Quality of Bowel Preparation Using the Aronchick Scale ( Score 1+2)SPMC1D100Participants
Quality of Bowel Preparation Using the Aronchick Scale ( Score 1+2)SPMC2D134Participants
Quality of Bowel Preparation Using the Aronchick Scale ( Score 1+2)PEGA1D121Participants
Quality of Bowel Preparation Using the Aronchick Scale ( Score 1+2)PEGA2D55Participants
Tolerance of Bowel Preparation Assessed by 5 Point VAS ( Score 1+2)PEG1D56Participants
Tolerance of Bowel Preparation Assessed by 5 Point VAS ( Score 1+2)PEG2D72Participants
Tolerance of Bowel Preparation Assessed by 5 Point VAS ( Score 1+2)SPMC1D134Participants
Tolerance of Bowel Preparation Assessed by 5 Point VAS ( Score 1+2)SPMC2D139Participants

Participant flow18

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDPEG1D174
Overall StudySTARTEDPEG2D174
Overall StudySTARTEDSPMC1D174
Overall StudySTARTEDSPMC2D174
Overall StudySTARTEDPEGA1D174
Overall StudySTARTEDPEGA2D174
Overall StudyCOMPLETEDPEG1D160
Overall StudyCOMPLETEDPEG2D162
Overall StudyCOMPLETEDSPMC1D166
Overall StudyCOMPLETEDSPMC2D159

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals18

The totals the trial posted for each group.

TotalGroupAffectedAt risk
Total, all-cause mortalityPEG1D00
Total, all-cause mortalityPEG2D00
Total, all-cause mortalitySPMC1D00
Total, all-cause mortalitySPMC2D00
Total, all-cause mortalityPEGA1D00
Total, all-cause mortalityPEGA2D00
Total, other adverse eventsPEG1D00
Total, other adverse eventsPEG2D00
Total, other adverse eventsSPMC1D00
Total, other adverse eventsSPMC2D00

Papers1

The papers the trial lists on ClinicalTrials.gov.

PMIDListed as
28944412BACKGROUND

Source PubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT02956057

GET https://conductscience.org/api/trials/v1/NCT02956057/registered